Subpopulations of peripheral leukocytes and cytokine mRNA expression levels were evaluated in scouring and healthy Holstein calves (age 10 ± 5 days; n=42) treated with a probiotic consisting of Lactobacillus plantarum, Enterococcus faecium and Clostridium butyricum. The calves were assigned to the scouring or healthy group and then subdivided into pathogen-positive treated (n=8), pathogen-positive control (n=8), pathogen-negative treated (n=6), pathogen-negative control (n=6), healthy treated (n=6) and healthy control (n=8) groups. A single dose of the probiotic (3.0 g/100 kg body weight) was given to each calf in the treatment groups for 5 days. Blood samples were collected on the first day of scour occurrence (day 0) and on day 7. In the scouring calves, smaller peripheral leukocyte subpopulations and cytokine mRNA expression levels were noted on day 0. The numbers of CD3(+) T cells; CD4(+), CD8(+) and WC1(+) γδ T cell subsets; and CD14(+), CD21(+) and CD282(+) (TLR2) cells were significantly increased in the scouring and healthy treated calves on day 7. Furthermore, interleukin-6, tumor necrosis factor-alpha and interferon-gamma mRNA expression was elevated in the peripheral leukocytes of the scouring and healthy treated calves on day 7. The scouring calves given the probiotic recovered on day 7. A significantly smaller number of peripheral leukocytes and lower cytokine mRNA expression level might be induced by scouring in calves. Repeated probiotic administration might stimulate cellular immunity and encourage recovery from scouring in pre-weaning Holstein calves.
Subpopulations of peripheral leukocytes and cytokine mRNA expression levels were evaluated in scouring and healthy Holstein calves (age 10 ± 5 days; n=42) treated with a probiotic consisting of Lactobacillus plantarum, Enterococcus faecium and Clostridium butyricum. The calves were assigned to the scouring or healthy group and then subdivided into pathogen-positive treated (n=8), pathogen-positive control (n=8), pathogen-negative treated (n=6), pathogen-negative control (n=6), healthy treated (n=6) and healthy control (n=8) groups. A single dose of the probiotic (3.0 g/100 kg body weight) was given to each calf in the treatment groups for 5 days. Blood samples were collected on the first day of scour occurrence (day 0) and on day 7. In the scouring calves, smaller peripheral leukocyte subpopulations and cytokine mRNA expression levels were noted on day 0. The numbers of CD3(+) T cells; CD4(+), CD8(+) and WC1(+) γδ T cell subsets; and CD14(+), CD21(+) and CD282(+) (TLR2) cells were significantly increased in the scouring and healthy treated calves on day 7. Furthermore, interleukin-6, tumor necrosis factor-alpha and interferon-gamma mRNA expression was elevated in the peripheral leukocytes of the scouring and healthy treated calves on day 7. The scouring calves given the probiotic recovered on day 7. A significantly smaller number of peripheral leukocytes and lower cytokine mRNA expression level might be induced by scouring in calves. Repeated probiotic administration might stimulate cellular immunity and encourage recovery from scouring in pre-weaning Holstein calves.
Calves are born with a naive immune system, and appropriate development of the
gastrointestinal tract (GIT) microbiota in the early weeks of life is crucial for a functional
immune system [25, 27, 39]. GIT diseases are characterized by
acute intestinal inflammation, much of which is thought to be due to inappropriate activation
of the immune system in calves [19, 22]. Greater vulnerability to invasive infections and the
development of GIT disorders, such as scouring, are associated with the immaturity of the
immune system of calves at birth, although the specific mechanism is unclear. Regulation by
the immune-stimulatory effects of probiotics may contribute to the treatment of scouring in
calves [26]. Probiotics contribute to the homeostasis
of the bacterial flora in the GIT, improving animal health and protecting calves against
infection [35, 36]. Lactic acid bacteria (LAB) probiotics are known to help with GIT colonization
via the competitive exclusion of undesirable microorganisms and the development of a
homeostatic gastrointestinal environment in calves [1,
12, 18]. LAB
probiotics are also known to have a beneficial impact on intestinal infections and are
commonly used to treat calf scouring [19]. More
recently, in vivo studies have examined their immune-stimulatory effects in
calves [26, 35,
36]. In cases of inadequate initial bacterial
colonization, probiotics can be used to achieve a balanced immune response [17]. Therefore, the immune-modulating effect of probiotics
is likely more appropriate for young calves, when the intestinal bacterial inhabitants are
less well-established. The phagocytic activities of leukocytes have been reported to be
increased in the peripheral blood of calves following the administration of a probiotic
consisting of Lactobacillus plantarum [18]. A number of systemic immune markers, including CD8+ cells, increased
in response to treatment with a probiotic in scouring calves [26]. In adult cattle, the immune-stimulatory effect of a probiotic containing
Enterococcus faecium and Saccharomyces cerevisiae has been
recognized in feedlot steers and dairy cows [7, 20]. In the intestine, Clostridium
butyricum as a probiotic may increase the resistance of the gut to pathogen
invasion by inducing the secretion of anti-inflammatory cytokines [11]. The stimuli provided by probiotics are essential for the development
of a fully functional and balanced immune system, including the homing of B and T cells to the
lamina propria [4]. It has generally been assumed that
some probiotic strains predominantly induce cytokine mRNA expression in leukocytes, promote T
cell development and augment immune defense to prevent infections, thereby ameliorating
inflammatory diseases [7, 20, 33, 34]. Recently, we studied the effects of a probiotic on peripheral
leukocytes and their mRNA expression in healthy weaned calves (in press). However, the effect
of probiotics on subpopulations of peripheral leukocytes in scouring and healthy pre-weaning
calves is unknown. In the present study, the immune-stimulatory effects of a probiotic on
peripheral blood mononuclear cells (PBMCs) and their mRNA expression levels were investigated
in scouring and healthy pre-weaning Holstein calves.
MATERIALS AND METHODS
Animals and treatment: The experimental design was approved by the
Laboratory Animal Care and Use Committee of Iwate University, Iwate, Japan. Forty-two
scouring and healthy pre-weaning Holstein calves (age 10 ± 5 days) housed in two commercial
dairy farms were used in the experiment. All calves were examined clinically, and the
scouring status of each calf was inspected. The scour condition was watery to muddy yellow,
and the appetite of the scouring calves was almost normal. The calves were assigned to
treatment and corresponding control groups based on the type of scouring (pathogenic or
non-pathogenic) and clinically healthy (non-scouring) status. The treatment groups included
scouring pathogen-positive treated (PPT; n=8), scouring pathogen-negative treated (PNT; n=8)
and healthy treated (HT; n=6) calves. The corresponding control groups included scouring
pathogen-positive control (PPC; n=6) and pathogen-negative control (PNC; n=6) calves, and
healthy control (HC; n=8) calves without probiotic treatment were used as the main control
group. All calves received colostrum at birth and were fed a milk replacement twice
daily.Treatment of the calves began on the first day of scour occurrence (day 0). After a
clinical examination and the collection of blood and stool samples, a probiotic (Miyarisan
Pharmaceutical Co., Ltd., Tokyo, Japan) that included L. plantarum strain
220 (9 × 106 colony forming units [CFU]/g), E. faecium strain 26
(9 × 105 CFU/g) and C. butyricum strain Miyari (9 ×
104 CFU/g) was administered to each of the calves in the treatment groups once
daily at a dose of 3.0 g/100 kg body weight (BW) for 5 days. The probiotic was mixed with a
milk replacement and fed to each calf in the morning. The scouring calves were not treated
by any other medicine or electrolyte therapy, although all calves had access to fresh water
ad libitum.Blood collection and PBMC isolation: Blood samples were collected on days
0 and 7. A blood specimen (6 ml) was collected in a heparinized tube (BD
Vacutainer Systems, Plymouth, U.K.) and used to isolate PBMCs for flow cytometric analysis.
Blood (4 ml) was also collected in two EDTA tubes (BD Vacutainer; Becton
Dickinson, Franklin Lakes, NJ, U.S.A.) and used for total RNA extraction from peripheral
leukocytes and for white blood cell (WBC) counts. The WBC count was determined using an
automatic hematology analyzer device equipped with software for bovine samples (pocH-100iV
Diff; Sysmex, Kobe, Japan). The percentage of PBMCs was determined using the hemogram method
with the Dif-Quick staining protocol. PBMCs were isolated as described by Ohtsuka et
al. [27]. To purify PBMCs and to lyse red
blood cells, 2 ml of the heparinized blood was mixed with 8
ml of 0.83% ammonium chloride solution. After 5 min at room temperature,
the samples were centrifuged (2,000 rpm, 10 min and 4°C). The leukocytes were then purified
by washing twice in phosphate-buffered saline (PBS; pH 7.4) followed by centrifugation
(2,000 rpm, 5 min and 4°C). After the final wash, the cell pellet was diluted in 500
µl of PBS, and the cells were counted. The cell concentration was then
adjusted to 1 × 107/ml in PBS, and the cells were kept at 4°C
until they were used for flow cytometry.Flow cytometry: The primary monoclonal antibodies used in the present
study are shown in Table 1. Flow cytometry was performed as described by Ohtsuka et al.
[27]. PBMCs were labeled with the primary antibody
and incubated for 60 min at 4°C. CD3+ T cells and each of the
CD4+ and CD8+ T cell subsets were additionally labeled with a
monoclonal antibody against CD45R to mark pan-leukocytes. After incubation, the cells were
washed twice to remove unbound antibodies. The labeled cells were then stained with specific
purified IgG conjugated to a phycoerythrin (PE) polyclonal secondary antibody (goat
anti-mouse IgG1 RPE; AbD Serotec, Kidlington, Oxford, U.K.) or fluorescein
isothiocyanate (FITC)-conjugated antibody (goat anti-mouse IgG or IgM FITC; Southern
Biotech, Birmingham, AL, U.S.A.) and incubated for 30 min at 4°C. After washing twice, the
stained cells were diluted in 500 µl of PBS. Flow cytometry was performed
using a FACScan analyzer (Becton Dickinson) equipped with a computer running Cell Quest
software (Becton Dickinson).
mAb, monoclonal antibody; TCR, T cell receptor; PTPR, protein tyrosine phosphatase
receptor; LPS, lipopolysaccharide; CR2, complement component receptor 2; TLR2,
toll-like receptor 2.Total RNA extraction from leukocytes and cDNA synthesis: Total RNA was
extracted from 1 ml of whole blood leukocytes using the SV Total RNA
Isolation System (Promega, Tokyo, Japan). Trace genomic DNA in the crude total RNA samples
was removed by incubation with 4–6 U of DNase I per 100 mg of total RNA (Ambion, Austin, TX,
U.S.A.) for 30 min at 37°C. The concentration of total RNA was verified on a 1% agarose gel,
and the purity was determined using a NanoDrop ND-1000 spectrophotometer (NanoDrop
Technologies, Rockland, DE, U.S.A.). cDNA was prepared using an oligo (dT) primer and a
thermal cycler (MyCycler; Bio-Rad, Tokyo, Japan). cDNA synthesis was performed using the
ImProm Reverse Transcription System (Promega). The cDNA was stored at −80°C until it was
used for real-time PCR.Real-time PCR: Real-time PCR was performed using an iQ SYBR Green Supermix
Kit (Bio-Rad) as described previously [23]. Specific
individual cytokine primer sequences and the internal standard gene used (β-actin) are shown
in Table 2. Amplification was performed using a Mini Opticon (Bio-Rad) thermal cycler
with the following profile: 1 cycle of 95°C for 2 min followed by 45 cycles of 95°C for 30
sec, and 65 or 59°C for 30 sec and 74°C for 30 sec followed by 74°C for 7 min. A melting
curve analysis was performed from 50 to 95°C with readings every 0.5°C (holding for
5
sec). Relative gene expression was calculated using the comparative threshold
cycle number (2–ΔCt) method, as described by Livak and Schmitge [23]. The results are summarized as ΔCt values, where ΔCt
is the difference in the threshold cycle for the target and β-actin, as an internal
control.
Table 2.
Primers used for real-time PCR
Gene
GenBank acc. no.
Sequence (5′→3′)
Annealing temperature (°C)
Concentration (nM)
β-Actin
AY141970
F: GGCCGAGCGGAAATCG
65
750
R: GCCATCTCCTGCTCGAAGTC
IL-6
NM173923
F: GTCTTCAAACGAGTGGGTAAAG
65
250
R: TGACCAGAGGAGGGAATGC
IL-8
NM173925
F: CACTGTGAAAATTCAGAAATCATTGTTA
59
250
R: CTTCACAAATACCTGCACAACCTTC
TNF-α
Z48808
F: CGGTGGTGGGACTCGTATG
65
750
R: GCTGGTTGTCTTCCAGCTTCA
IFN-γ
NM174086
F: TAGGCAAGTCTATGGGATTTC
59
250
R: GCATTCATTACATCATCAAGTG
The values (cells/µl) represent the means ± SE. a) Pathogen-positive
control (n=8). b) Pathogen-positive treated (n=6). c) Pathogen-negative control (n=8).
d) Pathogen-negative treated (n=6). * Compared with day 0 in the same group
(P<0.01). # Compared with the values of the corresponding
control groups (P<0.05).The values (cells/µl) represent the means ± SE. a) Healthy control
calves without treatment (n=8). b) Healthy treated calves (received 3.0 g/100 kg of
probiotic for 5 days; n=6). *Compared with day 0 in the same group
(P<0.01). # Compared with the healthy controls on the same day
(P<0.05).Stool analysis: The common pathogens considered essential for calf
scouring in the field were examined using stool samples from the calves in the scouring
groups. On the first day of scouring, stool samples were obtained from each calf by
mechanical stimulation of the anus and preserved in a sterilized tube. Deoxycholate hydrogen
sulfide-lactose agar (Elken Chemical Co., Tokyo, Japan) medium was used for the recognition
of Salmonella and Escherichia coli according to the
methods of Ishihara et al. [15]. The
Cryptosporidium parvum test strip BIO K 155 (Bio-X Diagnostics, Jemelle,
Belgium) was used according to the manufacturer’s instructions with 0.1 g of stool sample
and was evaluated visually. For the detection of coccidia spores, a previously described
microscopic method was used [22]. For rotavirus, a
specific test strip (SA Scientific, San Antonio, TX, U.S.A.) was used following the product
use recommendations. Among the scouring calves diagnosed as pathogen-positive (n=16), the
pathogens found were rotavirus (43%), coccidian Eimeria bovis and/or
Eimeria zuernii (25%), C. parvum (19%), E.
coli (13%) and Salmonella (0%). Those calves with negative stool
tests were assigned to the non-pathogenic scouring groups, and clinically healthy calves
without scouring were placed in the healthy groups. The scouring status of each calf was
inspected every day. Reduced occurrence of scouring and an improvement in clinical status
were noted in the probiotic-treated calves on day 7.Statistical analysis: The number of CD-positive or -negative cells was
calculated from the percentages of leukocytes gated by flow cytometry and total PBMCs. The
values are expressed as means ± standard error (SE). GraphPad Prism ver.5.01 software (La
Jolla, CA, U.S.A.) was used for the statistical calculations and one-way ANOVA, and the
Kruskal-Wallis test was subsequently used to evaluate differences among the groups. A
P-value<0.05 was considered significant.
RESULTS
Subpopulations of peripheral leukocytes: Compared with the values of the
HC and HT groups on day 0, a significantly lower (P<0.05) number of
CD3+ T cells; CD4+, CD8+ and WC1+ γδ T cell
subsets; and CD14+ cells were noted in the peripheral blood of scouring PPT and
PPCcalves. On day 0, the numbers of CD3+ T cells; the
CD4+, CD8+ and WC1+ γδ T cells subsets; and
CD14+ cells were lower (P<0.05) in the PPT and PPC groups
than in the other groups. The number of CD21+ cells was similar among the
scouring and healthy groups on day 0 (Fig. 1). Compared to the HC group, CD3+ T cells; the CD4+,
CD8+ and WC1+ γδ T cell subsets; and CD14+ and
CD21+ cells were increased (P<0.05) in the scouring PPT,
PNT and PPC groups on day 7. However, the numbers of CD8+ and CD21+
cells were unchanged in the scouring PNC group on day 7. The values among the scouring PPT,
PNT, PPC and PNC groups were not significantly different on day 7. Moreover, compared with
the values on day 0 and those of the HC group, an increased (P<0.05)
number of CD3+ T cells; the CD4+, CD8+ and WC1+
γδ T cell subsets; and CD14+ and CD21+ cells were noted in the HT
group on day 7. Compared with the value on day 0, WC1+ γδ T cells were increased
(P<0.05) in the HC group on day 7. Likewise, compared with the values
on day 0, PBMCs were increased (P<0.05) in the scouring PPT, PNT and HT
groups on day 7. A discrete analysis of the data indicated that the numbers of
CD45R+ and CD45R− T cells were increased
(P<0.05) in the proportion of CD3+
(CD3+D45R+/CD45R−) T cells, CD4+
(CD4+CD45R+/CD45R−) and CD8+
(CD8+CD45R+/CD45R−) T cell subsets in the scouring PPT,
PNT, PPC and HT groups on day 7, compared to the values on day 0 in the same group or the HC
group. However, the values were increased (P<0.05) only in the number of
CD3+ (CD3+CD45R+) T cells and CD4+
(CD4+CD45R+) T cell subset in the scouring PNC group on day 7. The
values were not significantly different among the scouring PPT, PNT, PPC and PNC groups
(Table 3A and 3B). Peripheral
CD282+ [toll-like receptor 2 (TLR2)] monocytes were evaluated only in the
scouring PPT, PNT, HT and HC groups. Similar to that of the T cell subpopulations, a
significantly lower (P<0.05) number of peripheral TLR2+
monocytes were noted in the scouring calves on day 0. However, the number of
TLR2+ monocytes was increased (P<0.05) in the scouring PPT,
PNT and HT groups on day 7, compared with the values on day 0 and that of the HC group
(Fig. 2).
Fig. 1.
The numbers of CD3, CD4, CD8, CD14, CD21 and WC1 cells in the peripheral blood of the
scouring PPT (n=8), PPC (n=8), PNT (n=6), PNC (n=6), HT (n=6) and HC (n=8) groups.
Calves in the treated groups were given 3.0 g/100 kg BW of the probiotic once daily
for 5 days, and calves without probiotic treatment served as corresponding controls.
The values represent the mean ± SE. * Compared to day 0 in the same group.
# Compared to the HC group (P<0.05). The first day of
scouring occurrence and probiotic treatment was designated as day 0.
Table 3A.
Numbers of peripheral blood mononuclear cells (PBMCs) and CD45R−
/CD45R+ T cells in the scouring probiotic-treated and scouring control
calves
PPCa)
PPTb)
PNCc)
PNTd)
Day 0
Day 7
Day 0
Day 7
Day 0
Day 7
Day 0
Day 7
PBMCs
4,231 ± 430
5,658 ± 952
3,822 ± 313
5,947 ± 554*
4,427 ± 495
5,126 ± 425
4,140 ± 422
5,610 ± 393*
CD3+CD45R−
1,088 ± 103
2,656 ± 565*
1,064 ± 85
2,342 ± 282*
1,185 ± 79
2,558 ± 401*
1,375 ± 127
2,228 ± 268*
CD3+CD45R+
361 ± 28
1,305 ± 288*
564 ± 27
1,394 ± 150*
678 ± 85
968 ± 160*
552 ± 60
1,419 ± 131*#
CD4+CD45R−
133 ± 18
377 ± 53*
73 ± 14
320 ± 47*
111 ± 17
287 ± 75*
155 ± 41
205 ± 25*
CD4+CD45R+
177 ± 29
978 ± 144*
264 ± 23
963 ± 151*
450 ± 98
654 ± 58*
344 ± 63
1,049 ± 130*#
CD8+CD45R−
67 ± 15
284 ± 41*
80 ± 43
201 ± 22*
58 ± 7.0
96 ± 15
44 ± 12
113 ± 32*
CD8+CD45R+
238 ± 41
409 ± 73*
204 ± 16
710 ± 142*#
290 ± 51
305 ± 60
328 ± 46
505 ± 52*#
The values (cells/µl) represent the means ± SE. a) Pathogen-positive
control (n=8). b) Pathogen-positive treated (n=6). c) Pathogen-negative control (n=8).
d) Pathogen-negative treated (n=6). * Compared with day 0 in the same group
(P<0.01). # Compared with the values of the corresponding
control groups (P<0.05).
Table 3B.
Numbers of peripheral blood mononuclear cells (PBMCs) and
CD45R−/CD45R+ T cell subpopulations in the healthy
probiotic-treated and healthy control calves
HCa)
HTb)
Day 0
Day 7
Day 0
Day 7
PBMCs
4,500 ± 238
5,148 ± 476
3,808 ± 258
7,218 ± 365*
CD3+CD45R−
1,621 ± 116
1,725 ± 198
1,498 ± 98
2,003 ± 491*
CD3+CD45R+
979 ± 71
1,114 ± 152
1,042 ± 45
1,815 ± 105*#
CD4+CD45R−
128 ± 34
219 ± 51
108 ± 21
284 ± 22*
CD4+CD45R+
482 ± 81
439 ± 81
501 ± 71
1,307 ± 96*#
CD8+CD45R−
52 ± 12
68 ± 11
50 ± 7.5
101 ± 14*
CD8+CD45R+
409 ± 50
502 ± 70
421 ± 22
693 ± 66*
The values (cells/µl) represent the means ± SE. a) Healthy control
calves without treatment (n=8). b) Healthy treated calves (received 3.0 g/100 kg of
probiotic for 5 days; n=6). *Compared with day 0 in the same group
(P<0.01). # Compared with the healthy controls on the same day
(P<0.05).
Fig. 2.
Number of TLR2 (CD282) cells in the peripheral blood of the scouring PPT (n=8), PNT
(n=6), HT (n=6) and HC (n=8) groups. Calves in the treated groups were given 3.0 g/100
kg BW of the probiotic once daily for 5 days, and calves without probiotic treatment
served as corresponding controls. The values represent the mean ± SE. * Compared to
day 0 in the same group. # Compared to the HC group
(P<0.05). The first day of scouring occurrence and probiotic
treatment was designated as day 0.
The numbers of CD3, CD4, CD8, CD14, CD21 and WC1 cells in the peripheral blood of the
scouring PPT (n=8), PPC (n=8), PNT (n=6), PNC (n=6), HT (n=6) and HC (n=8) groups.
Calves in the treated groups were given 3.0 g/100 kg BW of the probiotic once daily
for 5 days, and calves without probiotic treatment served as corresponding controls.
The values represent the mean ± SE. * Compared to day 0 in the same group.
# Compared to the HC group (P<0.05). The first day of
scouring occurrence and probiotic treatment was designated as day 0.Number of TLR2 (CD282) cells in the peripheral blood of the scouring PPT (n=8), PNT
(n=6), HT (n=6) and HC (n=8) groups. Calves in the treated groups were given 3.0 g/100
kg BW of the probiotic once daily for 5 days, and calves without probiotic treatment
served as corresponding controls. The values represent the mean ± SE. * Compared to
day 0 in the same group. # Compared to the HC group
(P<0.05). The first day of scouring occurrence and probiotic
treatment was designated as day 0.mRNA expression of cytokines: Compared with the value for the HC calves,
the mRNA expression levels of interleukin (IL)-6 and interferon-gamma (IFN-γ) were lower
(P<0.05) in the scouring PPT, PNT, PPC and PNC groups on day 0. The
mRNA expression level of tumor necrosis factor-alpha (TNF-α) was lower
(P<0.05) in the scouring PPT and PPC groups, but the values were greater
in the scouring PNT, PNC, HT and HC groups on day 0 (Fig.
3). IL-6, IFN-γ and TNF-α mRNA expression was increased (P<0.05) in
the PPT, PNT, PPC, PNC and HT groups on day 7. Furthermore, compared to day 0, the TNF-α
mRNA expression level was higher (P<0.05) in the HC group on day 7. The
mRNA expression level of IL-8 was similar between the scouring and healthy calves on day 0,
but was elevated (P<0.05) in the scouring PPT and PPC groups on day 7.
Compared to the HC group, the expression of IL-8 mRNA was slightly higher in the HT group on
day 7, but the differences were not statistically significant.
Fig. 3.
Relative mRNA expression of IL-6, IL-8, TNF-α and IFN-γ in the peripheral blood of
the scouring PPT (n=8), PPC (n=8), PNT (n=6), PNC (n=6), HT (n=6) and HC (n=8) groups.
Calves in the treated groups were given 3.0 g/100 kg BW of the probiotic once daily
for 5 days, and calves without probiotic treatment served as corresponding controls.
The values represent the mean ± SE.* Compared to day 0 in the same group. #
Compared to the HC group (P<0.05). The first day of scouring
occurrence and probiotic treatment was designated as day 0.
Relative mRNA expression of IL-6, IL-8, TNF-α and IFN-γ in the peripheral blood of
the scouring PPT (n=8), PPC (n=8), PNT (n=6), PNC (n=6), HT (n=6) and HC (n=8) groups.
Calves in the treated groups were given 3.0 g/100 kg BW of the probiotic once daily
for 5 days, and calves without probiotic treatment served as corresponding controls.
The values represent the mean ± SE.* Compared to day 0 in the same group. #
Compared to the HC group (P<0.05). The first day of scouring
occurrence and probiotic treatment was designated as day 0.
DISCUSSION
We recently studied the effects of a probiotic consisting of L. plantarum,
E. faecium and C. butyricum on the peripheral leukocyte
subpopulations and cytokine mRNA expression levels in healthy weaned calves (in press). In
the present study, peripheral leukocyte subpopulations and their cytokine mRNA expression
levels were evaluated in the field in scouring and healthy pre-weaning calves to clarify the
immune-stimulatory effects of the same probiotic agent.Some reports have indicated that a probiotic including LAB reduced the rate of GIT
disorders in calves [1, 26, 35, 36]. Increased intestinal LAB might stimulate the gut epithelial and
associated lymphoid tissues and may activate local immune responses in the intestine [12]. It was also suggested that a decreased number of
peripheral leukocytes, including CD8+ and WC1+ γδ T cells, might
result in a high risk of calf scouring [27].
Similarly, a lower number of CD4+ and CD8+ cells and reduced cytokine
mRNA expression levels were noted in neonates with diarrhea, compared with healthy children
[9, 37]. In
agreement with a previous report by Ohtsuka et al. [27], the numbers of CD4+, CD8+ and WC1+
γδ T cell subsets and of CD14+ and TLR2+ cells were significantly
lower in scouring calves in the present study. Probiotics are known to affect the host
immune system in different ways, including inducing greater antibody production and
increasing epithelial barrier integrity, the upregulation of cell-mediated immunity,
increased TLR signaling, enhanced dendritic cell (DC)-T cell interactions and heightened T
cell associations [5, 18, 32]. The immune-stimulating properties
of a Bacillus-based probiotic were suggested by the increase in peripheral
blood CD8+ cells in scouring calves compared with controls [26]. Furthermore, the number of CD4+ cells increased in
response to a probiotic consisting of C. butyricum in dairy cows [20]. In a study of calf PBMCs, the phagocytic activities
of leukocytes were increased by a probiotic consisting of L. plantarum
[18]. In addition, selective effects of a probiotic
including Lactobacillus were reported for T cell activation,
CD8+ cell activity and cytokine production [5]. Most peripheral T cell subpopulations have CD3 expressed on their surface,
which might appear as a signal-transducing unit for the T cell receptor (TCR) [32]. Similar to our recent study using the same probiotic
agent in healthy weaned calves, the proportion of CD3+CD45R+ T cells
was marginally higher in the systemic circulation of pre-weaning scouring and HT calves.
Similar to previous reports, a greater presence of CD45R+ T cells might
facilitate the regular activation of T cell subsets in probiotic-treated calves [26]. In contrast, bovineWC1+ γδ T cells are
known to be immune suppressors and are involved in secreting IFN-γ [13, 28, 29]. WC1+ γδ T cells can respond to stimulation via the TCR
and through CD3 stimulation, leading to the induction of IFN-γ expression in these cells
[32]. Early production of IFN-γ by γδ T cells may
have a role in linking innate and adaptive immune responses [29]. Furthermore, bovine γδ T lymphocyte subsets are activated indirectly through
cytokines secreted by T cells, antigen-presenting cells and other accessory cells [13, 28, 31]. Our results show that the number of WC1+
γδ T cells increased in both the scouring and HT groups and was associated with increased
IFN-γ expression. In addition, WC1+ γδ T cells were also greater in number in the
HC group. This is in accordance with a previous report, which noted that γδ cell subsets
were significantly larger in fetal and maturing calves than in mature animals [39].Probiotics including Lactobacillus and C.
butyricum induce the release of IL-6 and TNF-α, which are involved in
nonspecific immune responses [11]. It was previously
reported that pre-weaning calves given a probiotic had increased serum IgG and IFN-γ levels
[35]. Furthermore, probiotics including E.
faecium and C. butyricum or Lactobacillus
induced the production of pro- and anti-inflammatory cytokines, including IL-6, IFN-γ and
TNF-α, in human PBMCs [5, 14]. In the present study, increased IL-6, INF-γ and TNF-α mRNA
expression was observed in the scouring treated, HT and HC groups. In contrast, IL-8 mRNA
expression was unchanged, but it was elevated in the scouring groups. Greater expression of
IL-8 is likely related to neutrophil function and/or inflammatory stimulation in bovines
[2]. Therefore, IL-8 mRNA expression was changed
only in scouring calves, but not in healthy calves. It was reported that TNF-α mRNA
expression was related to age-related changes in intracellular cytokine production [9]. In the present study, a higher TNF-α mRNA expression
level was also noted in the healthy control calves.TLR expression is associated with bacterial immune stimulators, including LAB, in the GIT
of calves [25]. In our preliminary study, it was
revealed that calves given the probiotic had a stable ruminal pH compared to the controls.
It was also reported that a significant increase in ruminal pH was correlated with
increasing taxonomic units of Clostridia in the gastro-intestine of cattle
[30]. Therefore, improved diversity and bacterial
immigration might affect intestinal bacterial populations. However, the bacterial flora was
not evaluated in the present study. In bovines, the expression of TLR2 was obvious on
antigen-presenting cells with a high level expression on peripheral monocytes and
gastrointestinal macrophages [19, 21, 25]. Moreover,
bovineTLR2 cell surface molecules on monocyte-derived DCs and intestinal macrophages are
most responsible for the recognition of Gram-positive bacteria [3, 6, 10]. In human PBMCs, monocytes presenting TLRs played an important role
in Lactobacillus-induced immunological responses [5]. Mechanisms indicating a direct role for TLR2 include bacterial
reorganization by epithelial macrophages in calves [25]. However, CD14+ cells are involved with the TLR4 and MD2 complex,
which is essential for the response to most Gram-negative bacteria [19, 25]. Among probiotics,
Lactobacillus strains have a rigid cell wall that is resistant to
intracellular digestion and can stimulate intestinal macrophages presenting TLR2 to secrete
a large quantity of cytokines [33]. In the present
study, the numbers of CD14+ and TLR2+ cells were increased in the
scouring and HT calves compared to the controls. A B-cell receptor complex including CD21 is
present on mature B cells and ileal Peyer’s patch-derived B lymphocytes in young calves
[16]. The stimulation of CD21+ cells is
related to intestinal immune stimuli, and probiotics are known to trigger naive plasma cells
to become IgA-producing CD21+ B cells [12,
24, 38]. In
our study, the number of CD21+ cells was increased in the scouring and healthy
probiotic-treated calves on day 7.An interaction between probiotics and the host immune system leads to the interface of
intestinal immune cells, such as CD14+ and TLR+ cell macrophages or
DCs and to the release of cytokine stimulators by T and B cells [6, 8, 14]. The activation and balanced response of T cells is an important
component of the recovery from GIT disease in cattle [25, 38]. Probiotics contribute to
homeostasis of the intestinal bacterial flora and result in scouring recovery in young
calves [26, 35, 36].In the present study, a probiotic was administed to pre-weaning scouring calves for 5 days,
and stool samples were examined to discover the underlying cause of scouring. The scouring
PPT and PPC or PNT and PNC groups revealed a greater number of peripheral leukocytes and
higher cytokine mRNA expression levels on day 7, although the immune marker values were
slightly higher in the PPT and PPC groups compared with PNT and PNC groups. Higher immune
marker values on day 7 in the both pathogen-positive and pathogen-negative scouring groups
(PPT and PNT) might be induced by probiotic administration and scouring causers.
Furthermore, the increased numbers of circulating immune cells in HT group indicated the
immune-stimulatory effects of the probiotic, as suggested by previous studies [7, 20]. On the
other hand, the scouring calves given no probiotic (PPC and PNC groups) exhibited greater
expression of immune markers on day 7, which might be associated with the usual reaction of
immune system through the GIT disorders [37]. The
recovery of scouring in the calves given probiotic was in agreement with that in previous
reports [1, 12,
19, 26].
From these findings, probiotic administration to the scouring calves might be effective in
both pathogen-positive and pathogen-negative cases. In this study, serum IgG was not
analyzed. However, it was previously suggested that the serum IgG concentration was
increased by probiotic administration in pre-weaning calves [36].In conclusion, the administration of a bacteria-based probiotic resulted in increased
numbers of CD3+ T cells; CD4+, CD8+ and WC1+ γδ
T cells; and CD14+, CD21+ and TLR2+ cells in scouring PPT,
PNT and HT calves, compared with healthy controls. Moreover, higher IL-6, INF-γ and TNF-α
mRNA expression levels were noted in peripheral leukocytes, and the probiotic-treated calves
recovered from scouring. These findings demonstrate that the administration of a probiotic
elicits immunological changes in the systemic circulation of scouring and healthy calves.
Considering the effects of probiotics on immune markers in healthy calves, the repeated
treatment of healthy pre-weaning calves with a 5-day probiotic regimen could elevate the
levels of reduced immune markers, thereby reducing the incidence of scouring in young
calves.
Authors: Ivo G Boneca; Olivier Dussurget; Didier Cabanes; Marie-Anne Nahori; Sandra Sousa; Marc Lecuit; Emmanuel Psylinakis; Vassilis Bouriotis; Jean-Pierre Hugot; Marco Giovannini; Anthony Coyle; John Bertin; Abdelkader Namane; Jean-Claude Rousselle; Nadège Cayet; Marie-Christine Prévost; Viviane Balloy; Michel Chignard; Dana J Philpott; Pascale Cossart; Stephen E Girardin Journal: Proc Natl Acad Sci U S A Date: 2007-01-10 Impact factor: 11.205
Authors: Yuhuan Wang; Penelope H Dennehy; Harry L Keyserling; Kevin Tang; Jon R Gentsch; Roger I Glass; Baoming Jiang Journal: J Virol Date: 2007-01-31 Impact factor: 5.103
Authors: Christine Beecher; Mairéad Daly; Donagh P Berry; Katja Klostermann; James Flynn; William Meaney; Colin Hill; Tommie V McCarthy; R Paul Ross; Linda Giblin Journal: J Dairy Res Date: 2009-05-18 Impact factor: 1.904
Authors: Andrea T Borchers; Carlo Selmi; Frederick J Meyers; Carl L Keen; M Eric Gershwin Journal: J Gastroenterol Date: 2009-01-22 Impact factor: 7.527
Authors: Aad Hoek; Victor P M G Rutten; Jolanda Kool; Ger J A Arkesteijn; Ruth J Bouwstra; Ildiko Van Rhijn; Ad P Koets Journal: Vet Res Date: 2008-10-18 Impact factor: 3.683